Paul Burton
Presently, Paul Burton holds the position of Chief Medical Officer at Moderna, Inc. and Chief Global Medical Affairs Officer at Janssen Pharmaceuticals, Inc. He is also Member of Royal College of Surgeons.
Dr. Burton previously occupied the position of Vice President for Janssen Research & Development LLC.
Paul Burton received a doctorate from the University of London and a doctorate from Imperial College London.
Transactions
Date
Transaction
Value
| 11/07/2022 | 192 | Disposition at $158.68 per share. | 30,467 |
| 11/04/2022 | 402 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 08/08/2022 | 865 | Disposition at $185.1 per share. | 160,112 |
| 08/05/2022 | 1,609 | Derivative/Non-derivative trans. at $194.18 per share. | 312,435 |
